Hiroyuki Masuko
Muroran, 0518501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: November 08, 2024
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).
Journal: International journal of clinical oncology
Published: April 15, 2024
Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan.
Journal: Biological & pharmaceutical bulletin
Published: July 05, 2022
Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in Japan.
Journal: Journal of clinical pharmacy and therapeutics
Published: July 31, 2021
Inguinal hernias appearing after lateral lymph node dissection via extraperitoneal approach for advanced lower rectal cancer.
Journal: Hernia : the journal of hernias and abdominal wall surgery
Published: August 02, 2018
Pneumatosis Cystoides Intestinalis Secondary to Sunitinib Treatment for Gastrointestinal Stromal Tumor.
Journal: Case reports in gastroenterology
Published: March 19, 2018
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
Journal: The lancet. Gastroenterology & hepatology
Published: August 17, 2017
Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
Journal: International journal of clinical oncology
Published: June 14, 2017
The Primary Result of Prospective Randomized Multicenter Trial of New Spray-Type Bio-absorbable Adhesion Barrier System (TCD-11091) Against Postoperative Adhesion Formation.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: April 26, 2017
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
Journal: International journal of clinical oncology
Published: November 02, 2016
Last Updated: 09/26/2026